Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × Granulocyte Colony-Stimulating Factor × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 31 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Myelodysplastic Syndromes 17 Lymphoma, Non-Hodgkin 9 Multiple Myeloma 8 Leukemia, Biphenotypic, Acute 8 Hodgkin Disease 8 Leukemia 7 Burkitt Lymphoma 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Recurrence 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Hematologic Neoplasms 5 Anemia, Refractory, with Excess of Blasts 5 Neuroblastoma 4 Myeloproliferative Disorders 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large B-Cell, Diffuse 4 Leukemia, Myelomonocytic, Chronic 4 Breast Neoplasms 4 Rhabdomyosarcoma 3 Medulloblastoma 3 Lymphoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Sarcoma, Ewing 2 Sarcoma 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Myelomonocytic, Juvenile 2

Interventions

Cyclophosphamide 11 Prednisone 8 Doxorubicin 8 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 7 Vincristine 6 Brentuximab Vedotin 5 Azacitidine 5 fludarabine 4 Gemcitabine 4 Etoposide 4 romidepsin 3 pembrolizumab 3 belinostat 3 Dexamethasone 3 Biopsy 3 10-propargyl-10-deazaaminopterin 3 tazemetostat 2 ruxolitinib 2 Lenalidomide 2 Bendamustine Hydrochloride 2 venetoclax 1 tislelizumab 1 tipifarnib 1 thymoglobulin 1 sodium-iodide symporter 1 selinexor 1 relatlimab 1 pomalidomide 1 ixazomib 1 ivarmacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡